MedTrace Logo

A Study to Evaluate the Effect and Benefit of Diabetes Management Decision Support Software for Blood Glucose Control

NCT02934893 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2016-10-17

No results posted yet for this study

Summary

The benefit of drug therapy to persons with diabetes has been well established in clinical trials in terms of reducing cardiovascular risk, microvascular complications and mortality. However, treatment adherence and treatment effectiveness continue to be challenges in diabetes management.

Rimidi Diabetes has developed software algorithms to simulate the effect of anti-diabetic medications on an individual's glucose profile, allowing the clinician and their patient to visualize the anticipated outcome of a medical intervention. Use of this technology should allow for more targeted decision-making by the clinician and should facilitate a shared decision-making process with the PwD who is now privy to the thought process behind their medical management.

The proposed study is designed to test whether adding a decision support capability (Diabetes+Me Rx) that allows for modeling the anticipated effect of medication adjustments leads to improved glycemic control and a perceived benefit by healthcare providers and PwDs.

Conditions

Interventions

OTHER

Medication Management Clinic

referral to medication management clinic from primary care

OTHER

Diabetes+Me plus connected glucometer

Use of software and medication modeling tool as add on to medication management standard of care

Sponsors & Collaborators

  • Rimidi Diabetes, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Jardula, MD · Desert Oasis Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-10-31
Completion
2016-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934893 on ClinicalTrials.gov